Special Issue "Marine Anti-infective Agents"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: 31 October 2014

Special Issue Editor

Guest Editor
Prof. Dr. Miguel O. Mitchell
Science Content Editor, Late Night Labs, 1309 Middle Neck Dr. Apt. J Salisbury, MD 21804, USA
E-Mail: miguelmitchell@comcast.net
Phone: +1 410 422 2695
Interests: rational design and synthesis of antitubercular; anti-MRSA; anti-VRE and anticholinesterase agents; indole alkaloid natural product synthesis

Special Issue Information

Dear Colleagues,

This Special Issue will include both primary research and review articles covering anti-infective agents discovered in marine organisms. These anti-infective agents may be antibacterial, antifungal, antiprotozoan, antitubercular, and antiviral agents. These marine compounds may directlly interfere with microbial replication, block virulence (e.g., quorum sensing antagonists), or reverse multidrug resistance. Primary research articles must include full characterization (proton NMR, carbon-13 NMR, and high resolution mass spectral data) of all new compounds. Review articles must cite peer-reviewed literature from at least 2006-2011.

Prof. Dr. Miguel O. Mitchell
Guest Editor

Keywords

  • antibacterial
  • antitrypanosomal
  • antimycobacterial
  • antitubercular, tuberculosis
  • antifungal
  • antiviral
  • antimalarial, malaria
  • antiprotozoal
  • antimonial, Leishmania

Published Papers (15 papers)

by , , , ,  and
Mar. Drugs 2012, 10(5), 1103-1125; doi:10.3390/md10051103
Received: 15 April 2012; in revised form: 5 May 2012 / Accepted: 7 May 2012 / Published: 22 May 2012
Show/Hide Abstract | Cited by 3 | PDF Full-text (1020 KB) | HTML Full-text | XML Full-text

by  and
Mar. Drugs 2012, 10(5), 1037-1043; doi:10.3390/md10051037
Received: 5 March 2012; in revised form: 24 April 2012 / Accepted: 1 May 2012 / Published: 7 May 2012
Show/Hide Abstract | Cited by 2 | PDF Full-text (192 KB) | HTML Full-text | XML Full-text

by , ,  and
Mar. Drugs 2012, 10(4), 918-931; doi:10.3390/md10040918
Received: 5 March 2012; in revised form: 11 April 2012 / Accepted: 17 April 2012 / Published: 23 April 2012
Show/Hide Abstract | Cited by 6 | PDF Full-text (3759 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , , , , , , ,  and
Mar. Drugs 2012, 10(4), 762-774; doi:10.3390/md10040762
Received: 22 February 2012; in revised form: 13 March 2012 / Accepted: 20 March 2012 / Published: 28 March 2012
Show/Hide Abstract | Cited by 10 | PDF Full-text (408 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , , ,  and
Mar. Drugs 2012, 10(3), 521-538; doi:10.3390/md10030521
Received: 25 December 2011; in revised form: 3 February 2012 / Accepted: 6 February 2012 / Published: 24 February 2012
Show/Hide Abstract | Cited by 3 | PDF Full-text (973 KB) | HTML Full-text | XML Full-text

by , , ,  and
Mar. Drugs 2012, 10(1), 84-105; doi:10.3390/md10010084
Received: 28 November 2011; in revised form: 27 December 2011 / Accepted: 5 January 2012 / Published: 11 January 2012
Show/Hide Abstract | Cited by 5 | PDF Full-text (533 KB) | HTML Full-text | XML Full-text

by , , , , , ,  and
Mar. Drugs 2011, 9(12), 2537-2552; doi:10.3390/md9122537
Received: 22 September 2011; in revised form: 22 November 2011 / Accepted: 30 November 2011 / Published: 7 December 2011
Show/Hide Abstract | Cited by 16 | PDF Full-text (2518 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

by , ,  and
Mar. Drugs 2011, 9(12), 2514-2525; doi:10.3390/md9122514
Received: 8 September 2011; in revised form: 17 November 2011 / Accepted: 18 November 2011 / Published: 29 November 2011
Show/Hide Abstract | Cited by 13 | PDF Full-text (297 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2011, 9(11), 2236-2255; doi:10.3390/md9112236
Received: 22 September 2011; in revised form: 21 October 2011 / Accepted: 28 October 2011 / Published: 7 November 2011
Show/Hide Abstract | Cited by 6 | PDF Full-text (1227 KB) | HTML Full-text | XML Full-text
abstract graphic

by ,  and
Mar. Drugs 2010, 8(4), 1213-1262; doi:10.3390/md8041213
Received: 8 February 2010; in revised form: 2 April 2010 / Accepted: 12 April 2010 / Published: 14 April 2010
Show/Hide Abstract | Cited by 28 | PDF Full-text (531 KB) | HTML Full-text | XML Full-text

by , , , , , ,  and
Mar. Drugs 2010, 8(3), 498-518; doi:10.3390/md8030498
Received: 3 February 2010; in revised form: 1 March 2010 / Accepted: 2 March 2010 / Published: 5 March 2010
Show/Hide Abstract | Cited by 25 | PDF Full-text (277 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2010, 8(2), 373-380; doi:10.3390/md8020373
Received: 26 December 2009; in revised form: 2 February 2010 / Accepted: 4 February 2010 / Published: 23 February 2010
Show/Hide Abstract | Cited by 34 | PDF Full-text (183 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

by ,  and
Mar. Drugs 2009, 7(3), 401-434; doi:10.3390/md7030401
Received: 30 July 2009; in revised form: 20 August 2009 / Accepted: 24 August 2009 / Published: 26 August 2009
Show/Hide Abstract | Cited by 5 | PDF Full-text (193 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2009, 7(3), 268-313; doi:10.3390/md7030268
Received: 21 May 2009; in revised form: 22 June 2009 / Accepted: 25 June 2009 / Published: 30 June 2009
Show/Hide Abstract | Cited by 23 | PDF Full-text (890 KB) | HTML Full-text | XML Full-text
abstract graphic

by  and
Mar. Drugs 2009, 7(2), 130-152; doi:10.3390/md7020130
Received: 7 April 2009; in revised form: 20 April 2009 / Accepted: 22 April 2009 / Published: 23 April 2009
Show/Hide Abstract | Cited by 33 | PDF Full-text (328 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 18 March 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert